Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived granulocyte-macrophage colony-stimulating factor and interleukin-1β

Journal of Pharmacology and Experimental Therapeutics

Volumn 331, Issue 1, 2009, Pages 104-113

  Bosnar, Martina ^a   Bošnjak, Berislav ^a   Čužić, Snježana ^a   Hrvačić, Boška ^a   Marjanović, Nikola ^a   Glojnarić, Ines ^a   Čulić, Ognjen ^a   Parnham, Michael J ^a   Haber, Vesna Eraković ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CYTOKINE PRODUCTION; DRUG DOSE COMPARISON; LUNG LAVAGE; LUNG NEUTROPHILIA; MALE; MOUSE; NEUTROPHILIA; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AZITHROMYCIN; CELL LINE; CLARITHROMYCIN; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, INBRED BALB C; NEUTROPHIL INFILTRATION; NEUTROPHILS;

EID: 70349316444     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.155838     Document Type: Article

References (30)

1. Barnes PJ (2007) New molecular targets for the treatment of neutrophilic diseases. J Allergy Clin Immunol 119:1055-1062. (Pubitemid 46654167)
2. Bozinovski S, Jones J, Beavitt SJ, Cook AD, Hamilton JA, and Anderson GP (2004) Innate immune responses to LPS in mouse lung are suppressed and reversed by neutralization of GM-CSF via repression of TLR-4. Am J Physiol Lung Cell Mol Physiol 286:L877-L885. (Pubitemid 38365075)
3. Criqui GI, Solomon C, Welch BS, Ferrando RE, Boushey HA, and Balmes JR (2000) Effects of azithromycin on ozone-induced airway neutrophilia and cytokine release. Eur Respir J 15:856-862. (Pubitemid 30321841)
4. Crosbie PA and Woodhead MA (2009) Long-term macrolide therapy in chronic inflammatory airway diseases. Eur Respir J 33:171-181.
5. Culić O, Eraković V, Cepelak I, Barisić K, Brajsa K, Ferencić Z, Galović R, Glojnarić I, Manojlović Z, Munić V, et al. (2002) Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. Eur J Pharmacol 450:277-289.
6. Culić O, Eraković V, and Parnham MJ (2001) Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol 429:209-229.
7. Hillis GS, Pearson CV, Harding SA, Sutherland S, Ludlam CA, Marioni JC, Prescott RJ, Fox KA, and Flapan AD (2004) Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: a double-blind, randomized, placebo-controlled study. Am Heart J 148:72-79. (Pubitemid 38900481)
8. Hodge S, Hodge G, Jersmann H, Matthews G, Ahern J, Holmes M, and Reynolds PN (2008) Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 178:139-148. (Pubitemid 351957772)
9. Huffnagle GB, Traynor TR, McDonald RA, Olszewski MA, Lindell DM, Herring AC, and Toews GB (2000) Leukocyte recruitment during pulmonary Cryptococcus neoformans infection. Immunopharmacology 48:231-236. (Pubitemid 30674109)
10. Ivetić Tkalcević V, Bosnjak B, Hrvacić B, Bosnar M, Marjanović N, Ferencić Z, Situm K, Culić O, Parnham MJ, and Eraković V (2006) Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice. Eur J Pharmacol 539:131-138.
11. Kadota J, Sakito O, Kohno S, Sawa H, Mukae H, Oda H, Kawakami K, Fukushima K, Hiratani K, and Hara K (1993) A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 147:153-159. (Pubitemid 23025932)
12. Kaplanski G, Marin V, Montero-Julian F, Mantovani A, and Farnarier C (2003) IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol 24:25-29. (Pubitemid 35462110)
13. Kudoh S, Azuma A, Yamamoto M, Izumi T, and Ando M (1998) Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 157:1829-1832. (Pubitemid 28311266)
14. Lappalainen U, Whitsett JA, Wert SE, Tichelaar JW, and Bry K (2005) Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 32:311-318. (Pubitemid 40478306)
15. Leiva M, Ruiz-Bravo A, and Jimenez-Valera M (2008) Effects of telithromycin in in vitro and in vivo models of lipopolysaccharide-induced airway inflammation. Chest 134:20-29. (Pubitemid 352008759)
16. Martin TR (2000) Recognition of bacterial endotoxin in the lungs. Am J Respir Cell Mol Biol 23:128-132.
17. Maus UA, Waelsch K, Kuziel WA, Delbeck T, Mack M, Blackwell TS, Christman JW, Schlöndorff D, Seeger W, and Lohmeyer J (2003) Monocytes are potent facilitators of alveolar neutrophil emigration during lung inflammation: role of the CCL2-CCR2 axis. J Immunol 170:3273-3278. (Pubitemid 36302205)
18. Ou XM, Feng YL, Wen FQ, Wang K, Yang J, Deng ZP, Liu DS, and Li YP (2008) Macrolides attenuate mucus hypersecretion in rat airways through inactivation of NF-kappaB. Respirology 13:63-72.
19. Parchure N, Zouridakis EG, and Kaski JC (2002) Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of Chlamydia pneumoniae infection. Circulation 105:1298-1303. (Pubitemid 34260419)
20. Saito T, Yamamoto T, Kazawa T, Gejyo H, and Naito M (2005) Expression of toll-like receptor 2 and 4 in lipopolysaccharide-induced lung injury in mouse. Cell Tissue Res 321:75-88. (Pubitemid 40984841)
21. Sanz MJ, Nabah YN, Cerdá-Nicolás M, O'Connor JE, Issekutz AC, Cortijo J, and Morcillo EJ (2005) Erythromycin exerts in vivo anti-inflammatory activity downregulating cell adhesion molecule expression. Br J Pharmacol 144:190-201. (Pubitemid 40216117)
22. Schnyder-Candrian S, Quesniaux VF, Di Padova F, Maillet I, Noulin N, Couillin I, Moser R, Erard F, Vargaftig BB, Ryffel B, et al. (2005) Dual effects of p38 MAPK on TNF-dependent bronchoconstriction and TNF-independent neutrophil recruitment in lipopolysaccharide-induced acute respiratory distress syndrome. J Immunol 175:262-269. (Pubitemid 40884327)
23. Shinkai M, Foster GH, and Rubin BK (2006) Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 290:L75-L85.
24. Shinkai M, Henke MO, and Rubin BK (2008) Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action. Pharmacol Ther 117:393-405.
25. Standiford TJ, Kunkel SL, Phan SH, Rollins BJ, and Strieter RM (1991) Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem 266:9912-9918.
26. Tamaoki J, Tagaya E, Yamawaki I, Sakai N, Nagai A, and Konno K (1995) Effect of erythromycin on endotoxin-induced microvascular leakage in the rat trachea and lungs. Am J Respir Crit Care Med 151:1582-1588.
27. Ulich TR, Watson LR, Yin SM, Guo KZ, Wang P, Thang H, and del Castillo J (1991) The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate. Am J Pathol 138:1485-1496.
28. Whitman MS and Tunkel AR (1992) Azithromycin and clarithromycin: overview and comparison with erythromycin. Infect Control Hosp Epidemiol 13:357-368.
29. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, and Achong MK (1998) IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101:311-320. (Pubitemid 28067327)
30. Yamasawa H, Oshikawa K, Ohno S, and Sugiyama Y (2004) Macrolides inhibit epithelial cell-mediated neutrophil survival by modulating granulocyte macrophage colony-stimulating factor release. Am J Respir Cell Mol Biol 30:569-575. (Pubitemid 38457190)